Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)

Historic Other Non Operating Income for Eton Pharmaceuticals (ETON) over the last 3 years, with Q4 2024 value amounting to $169000.0.

  • Eton Pharmaceuticals' Other Non Operating Income rose 12112.5% to $169000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $169000.0, marking a year-over-year change of. This contributed to the annual value of $169000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Other Non Operating Income of $169000.0 as of Q4 2024, which was up 12112.5% from -$800000.0 recorded in Q4 2023.
  • Eton Pharmaceuticals' 5-year Other Non Operating Income high stood at $800000.0 for Q2 2023, and its period low was -$800000.0 during Q4 2023.
  • Over the past 3 years, Eton Pharmaceuticals' median Other Non Operating Income value was $267000.0 (recorded in 2021), while the average stood at $133500.0.
  • The largest annual percentage gain for Eton Pharmaceuticals' Other Non Operating Income in the last 5 years was 12112.5% (2024), contrasted with its biggest fall of 12112.5% (2024).
  • Eton Pharmaceuticals' Other Non Operating Income (Quarter) stood at $365000.0 in 2021, then plummeted by 319.18% to -$800000.0 in 2023, then soared by 121.12% to $169000.0 in 2024.
  • Its Other Non Operating Income stands at $169000.0 for Q4 2024, versus -$800000.0 for Q4 2023 and $800000.0 for Q2 2023.